Biotech IV Monitor

RYTM — Rhythm Pharmaceuticals Inc.

$7.0B market cap · 3 upcoming readouts tracked

Clinical trial readout dates for Rhythm Pharmaceuticals Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is March 2027.

Next readoutMarch 2027in ~4 months
Upcoming readouts31 Phase 3
Market cap$7.0B
Cash & investments$321M~8 quarters at last loss rate
Recent 8-K filings1latest 2026-11-03

Recently completed

The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.

Phase 3 Setmelanotide
Obesity Associated With Defects in Leptin-melanocortin Pathway · NCT06596135
June 2026
Primary data collected

Upcoming readouts

Phase 3 Setmelanotide
Hypothalamic Obesity; Multiple Pituitary Hormone Deficiency Genetic Form · NCT06760546
March 2027
Recruiting
Phase 1/2 Part A: RM-718 or placebo (matched to specific RM-718 dose cohort)
Hypothalamic Obesity; Prader-Willi Syndrome · NCT06239116
May 2027
Ongoing
Phase 2 Bivamelagon
Hypothalamic Obesity · NCT07156578
April 2028
Enrolling

Target dates already passed

These dates have elapsed; the company may have reported, or guidance may have shifted.

Phase 2 Setmelanotide
Prader-Willi Syndrome; Obesity · NCT06772597
November 2026
Ongoing

Cash position

Rhythm Pharmaceuticals Inc. reported $321M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-03). Its net loss for that quarter was $41M; at that rate the cash would last about 8 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.

Recent SEC filings

8-K Results of Operations — earnings, may carry pipeline updates2026-11-03

Companies working on similar indications

Discussion

No messages yet. If you follow RYTM, you can start the conversation.
Track RYTM in real time
See live implied volatility for RYTM and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on RYTM
Contact — questions or corrections about RYTM: dukeupt@gmail.com